BR0207141A - Propriedades antitumorais do 1,5-bis(4-hidroxi-3-metoxifenil)-penta-1,4-dien-3-ona e derivados e seu procedimento de obtenção - Google Patents

Propriedades antitumorais do 1,5-bis(4-hidroxi-3-metoxifenil)-penta-1,4-dien-3-ona e derivados e seu procedimento de obtenção

Info

Publication number
BR0207141A
BR0207141A BR0207141-0A BRPI0207141A BR0207141A BR 0207141 A BR0207141 A BR 0207141A BR PI0207141 A BRPI0207141 A BR PI0207141A BR 0207141 A BR0207141 A BR 0207141A
Authority
BR
Brazil
Prior art keywords
derivatives
dien
penta
bis
hydroxy
Prior art date
Application number
BR0207141-0A
Other languages
English (en)
Inventor
Jose Agustin Quincoces Suarez
Klaus Peseke
Marcus Kordian
Joao Ernesto De Carvalho
Luciana Konecny Kohn
Maria Aparecida Antonio
Heloiza Brunhari
Original Assignee
Jose Agustin Quincoces Suarez
Fundacao De Amparo A Pesquisa
Academia Paulista Anchieta S C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jose Agustin Quincoces Suarez, Fundacao De Amparo A Pesquisa, Academia Paulista Anchieta S C filed Critical Jose Agustin Quincoces Suarez
Priority to BR0207141-0 priority Critical patent/BRPI0207141B8/pt
Priority to EP03773364.9A priority patent/EP1572614B1/en
Priority to PT37733649T priority patent/PT1572614E/pt
Priority to JP2004554088A priority patent/JP2006508149A/ja
Priority to ES03773364.9T priority patent/ES2464268T3/es
Priority to PCT/BR2003/000177 priority patent/WO2004047716A2/en
Priority to AU2003283092A priority patent/AU2003283092A1/en
Priority to US10/536,667 priority patent/US7432401B2/en
Publication of BR0207141A publication Critical patent/BR0207141A/pt
Publication of BRPI0207141B1 publication Critical patent/BRPI0207141B1/pt
Publication of BRPI0207141B8 publication Critical patent/BRPI0207141B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/24Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
    • C07C49/245Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings
    • C07C49/248Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings having unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/08Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds

Abstract

"PROPRIEDADES ANTITUMORAIS DO 1,5-BIS(4-HIDROXI-3-METOXIFENIL)-PENTA-1,4-DIEN-3-ONA E DERIVADOS E SEU PROCEDIMENTO DE OBTENçãO". A presente patente de invenção relata as propriedades antitumorais do 1,5-Bis(4-hidroxi-3-metoxi-fenil)-penta-1,4-dien-3-ona e derivados e seu procedimento de obtenção: a amostra denominada composto 37 foi obtida com alto rendimento e pureza através da técnica ultrasónica apresentando atividade citostática (inibição do crescimento) nas concentrações avaliadas e atividade citocida (morte celular) a partir da concentração de 0,25 <109>g / mL frente a nove diferentes tipos de câncer humano. Este composto possui uma DL~ 50~, igual a 8,54g/Kg. Isto significa que este produto pode considerar-se como praticamente atóxico, sendo que a Doxorrubicina, medicamento anticancerígeno usado como referência em todos estes testes e um produto extremadamente tóxico (DL~ 50~ de 20mg/Kg) e não inibe o crescimento da linhagem celular Mama NCI-ADR (linhagem celular que expressa o fenótipo de resistência a múltiplas drogas), portanto nosso produto se mostrou com ação fortemente citostática. Os outros derivados apresentaram também forte ação citostática e citocida principalmente o composto denominado por EHB1.
BR0207141-0 2002-11-28 2002-11-28 processo para preparar compostos, uso de compostos, composição farmacêutica e método para tratamento de câncer BRPI0207141B8 (pt)

Priority Applications (8)

Application Number Priority Date Filing Date Title
BR0207141-0 BRPI0207141B8 (pt) 2002-11-28 2002-11-28 processo para preparar compostos, uso de compostos, composição farmacêutica e método para tratamento de câncer
EP03773364.9A EP1572614B1 (en) 2002-11-28 2003-11-28 Method for the preparation of 1,5-bis(4-hydroxy-3-metoxy-phenyl)-penta-1,4-dien-3-one
PT37733649T PT1572614E (pt) 2002-11-28 2003-11-28 Processo para a preparação de 1,5-bis(4-hidroxi-3-metoxifenil)- penta-1,4-dien-3-ona
JP2004554088A JP2006508149A (ja) 2002-11-28 2003-11-28 抗腫瘍特性を有する1,5−ビス(4−ヒドロキシ−3−メトキシフェニル)−ペンタ−1,4−ジエン−3−オンおよび誘導体の新規な製造方法
ES03773364.9T ES2464268T3 (es) 2002-11-28 2003-11-28 Procedimiento para la preparaci�n de 1,5-bis(4-hidroxi-3-metoxi-fenil)-penta-1,4-dien-3-ona
PCT/BR2003/000177 WO2004047716A2 (en) 2002-11-28 2003-11-28 New method for the preparation of 1,5-bis(4-hydroxy-3-metoxy-phenyl)-penta-1,4-dien-3-one and derivatives with antitumoral properties
AU2003283092A AU2003283092A1 (en) 2002-11-28 2003-11-28 New method for the preparation of 1,5-bis(4-hydroxy-3-metoxy-phenyl)-penta-1,4-dien-3-one and derivatives with antitumoral properties
US10/536,667 US7432401B2 (en) 2002-11-28 2003-11-28 Method for the preparation of 1,5-bis(4-hydroxy-3-metoxy-phenyl)-penta-1,4-dien-3-one and derivatives with antitumoral properties

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0207141-0 BRPI0207141B8 (pt) 2002-11-28 2002-11-28 processo para preparar compostos, uso de compostos, composição farmacêutica e método para tratamento de câncer

Publications (3)

Publication Number Publication Date
BR0207141A true BR0207141A (pt) 2004-06-29
BRPI0207141B1 BRPI0207141B1 (pt) 2019-04-16
BRPI0207141B8 BRPI0207141B8 (pt) 2021-05-25

Family

ID=67251474

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0207141-0 BRPI0207141B8 (pt) 2002-11-28 2002-11-28 processo para preparar compostos, uso de compostos, composição farmacêutica e método para tratamento de câncer

Country Status (8)

Country Link
US (1) US7432401B2 (pt)
EP (1) EP1572614B1 (pt)
JP (1) JP2006508149A (pt)
AU (1) AU2003283092A1 (pt)
BR (1) BRPI0207141B8 (pt)
ES (1) ES2464268T3 (pt)
PT (1) PT1572614E (pt)
WO (1) WO2004047716A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8841326B2 (en) 2004-02-12 2014-09-23 Stc.Unm Therapeutic curcumin derivatives
BRPI0602640B8 (pt) * 2006-07-06 2021-05-25 Anhanguera Educacional Ltda métodos de obtenção de penta-1,4-dien-3-onas e de cicloexanonas substituídas e derivados com propriedades antitumorais e antiparasitárias, processo para preparar 1,5-bis-(aril)-penta-1,4-dien-3-onas alquiladas e aciladas, processo para preparar 4-nitro-3,5-diaril-cicloexanonas substituídas, processo para preparar 2,6-dibenzilideno-4-nitro-3,5-diaril-cicloexanonas substituídas, processo para preparar uma mistura formada por quantidades determinadas dos compostos (1,5-bis(4-hidróxi-3-metóxi-fenil)penta-1,4-dien-3-ona) e (1,5-bis(3-metóxi-4-acetóxi-fenil)penta-1,4-dien-3-ona), compostos e seus usos, composição farmacêutica, método terapêutico para tratamento dos cânceres e composição sinérgica
CN103922911A (zh) * 2014-04-17 2014-07-16 上海应用技术学院 一种(1e,4e)-1,5-二(邻溴间甲氧基苯基)-1,4-戊二烯酮化合物及合成方法
CN114478256B (zh) * 2022-01-26 2024-02-23 安徽理工大学环境友好材料与职业健康研究院(芜湖) 一种新型姜黄素衍生物的制备方法及其抗肝癌的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521629A (en) * 1984-06-29 1985-06-04 American Cyanamid Company Method for the preparation of 1,5-bis-aryl-1,4-pentadien-3-ones
DE69028136T2 (de) * 1989-05-17 1997-01-23 Shionogi Seiyaku Kk Alkoxyiminoacetamid-Derivate und ihre Verwendung als pilztötendes Mittel
JP2856838B2 (ja) * 1990-04-30 1999-02-10 株式会社クラレ ステロイド誘導体の製造方法
JP2921104B2 (ja) * 1990-11-15 1999-07-19 東亞合成株式会社 β,γ―不飽和アルケニル基置換フェノール類の製造方法
JPH07215957A (ja) * 1994-02-03 1995-08-15 Takeda Chem Ind Ltd グリシジルエーテル類の製造法及びそのための連続製造装置
US6852248B1 (en) * 1999-04-02 2005-02-08 Hrl Laboratories, Llc Dopants for liquid-crystal devices
US6664272B2 (en) * 1999-12-03 2003-12-16 Emory University Curcumin analogs with anti-tumor and anti-angiogenic properties

Also Published As

Publication number Publication date
ES2464268T3 (es) 2014-06-02
AU2003283092A1 (en) 2004-06-18
BRPI0207141B8 (pt) 2021-05-25
BRPI0207141B1 (pt) 2019-04-16
EP1572614B1 (en) 2013-12-25
JP2006508149A (ja) 2006-03-09
WO2004047716A2 (en) 2004-06-10
US7432401B2 (en) 2008-10-07
AU2003283092A8 (en) 2004-06-18
WO2004047716A3 (en) 2004-08-19
EP1572614A2 (en) 2005-09-14
US20060128997A1 (en) 2006-06-15
PT1572614E (pt) 2014-04-03

Similar Documents

Publication Publication Date Title
Shen et al. Evaluation of the anti-inflammatory activity of zhankuic acids isolated from the fruiting bodies of Antrodia camphorata
Zhang et al. Ophiopogonin D attenuates doxorubicin-induced autophagic cell death by relieving mitochondrial damage in vitro and in vivo
AU654474B2 (en) Glycoalkaloids
Begum et al. Carandinol: First isohopane triterpene from the leaves of Carissa carandas L. and its cytotoxicity against cancer cell lines
Schwartz et al. Tumor regression with a combination of drugs interfering with the tumor metabolism: efficacy of hydroxycitrate, lipoic acid and capsaicin
Li et al. Cytotoxic compounds from invasive giant salvinia (Salvinia molesta) against human tumor cells
EP2213679B1 (en) Water-soluble triterpenephenol compounds having antitumor activity and the preparation thereof
Kong et al. Anti-inflammatory effect of a novel pectin polysaccharide from Rubus chingii Hu on colitis mice
Kwon et al. A caffeic acid-ferulic acid hybrid compound attenuates lipopolysaccharide-mediated inflammation in BV2 and RAW264. 7 cells
US8680251B2 (en) Triterpenoid 2-deoxy glycosides, method of preparation thereof and use thereof as medicaments
Deng et al. Synthesis of ursolic phosphonate derivatives as potential anti-HIV agents
BR0207141A (pt) Propriedades antitumorais do 1,5-bis(4-hidroxi-3-metoxifenil)-penta-1,4-dien-3-ona e derivados e seu procedimento de obtenção
Nvau et al. Antiparasitic and cytotoxic activity of bokkosin, a novel diterpene-substituted chromanyl benzoquinone from Calliandra portoricensis
Pongpamorn et al. Lycoclavatumide and 8β, 11α-dihydroxylycopodine, a new fawcettimine and lycopodine-type alkaloid from Lycopodium clavatum
Zi et al. New cannabidiol (CBD) derivatives: Synthesis, anti-inflammatory activity, and molecular docking
Gevrenova et al. Quantitative structure–activity relationship study on saponins as cytotoxicity enhancers
CN104592091A (zh) 一种含吲哚乙酸核心结构的化合物及其应用
Yin et al. Novel O-glycosidic gossypol isomers and their bioactivities
Ulrich et al. Biologically active biotin derivatives of schweinfurthin F
Khan et al. Synthesis of novel imbricatolic acid analogues via insertion of N-substituted piperazine at C-15/C-19 positions, displaying glucose uptake stimulation in L6 skeletal muscle cells
TW201247207A (en) Use of Lanosta-8,24-dien-3 β ,15 α ,21-triol for inhibition of tumor cell growth
Ghandourah et al. Antiproliferative effects of isoprenoids from Sarcophyton glaucum on breast cancer MCF-7 cells
Xing et al. Selective Antitumor Effect and Lower Toxicity of Mitochondrion-Targeting Derivatization of Triptolide
Piegang et al. Cycloartanes from Oxyanthus pallidus and derivatives with analgesic activities
Bruce et al. A suicide by thiopentone injection

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25C Requirement related to requested transfer of rights

Owner name: JOSE AGUSTIN QUINCOCES SUAREZ (BR/SP) , FUNDACAO D

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: JOSE AGUSTIN QUINCOCES SUAREZ (BR/SP) , FUNDACAO D

B25C Requirement related to requested transfer of rights

Owner name: JOSE AGUSTIN QUINCOCES SUAREZ (BR/SP) , FUNDACAO D

B25B Requested transfer of rights rejected

Owner name: JOSE AGUSTIN QUINCOCES SUAREZ (BR/SP) , FUNDACAO D

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25C Requirement related to requested transfer of rights

Owner name: JOSA AGUSTA-N QUINCOCES SUA REZ (BR/SP) ; FUNDAA

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: JOSE AGUSTIN QUINCOCES SUAREZ (BR/SP) ; FUNDACAO D

Free format text: ANULADA A PUBLICACAO CODIGO 25.3 NA RPI NO 2484 DE 14/08/2018 POR TER SIDO INDEVIDA.

B25D Requested change of name of applicant approved

Owner name: JOSE AGUSTIN QUINCOCES SUAREZ (BR/SP) ; FUNDACAO D

Owner name: JOSE AGUSTIN QUINCOCES SUAREZ (BR/SP) ; FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO (BR/SP) ; ACADEMIA PAULISTA ANCHIETA LTDA. (BR/SP)

B25A Requested transfer of rights approved

Owner name: JOSE AGUSTIN QUINCOCES SUAREZ (BR/SP) ; FUNDACAO D

Owner name: JOSE AGUSTIN QUINCOCES SUAREZ (BR/SP) ; FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO (BR/SP) ; ANHANGUERA EDUCACIONAL LTDA. (BR/SP)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/04/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/04/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/11/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 28/11/2022